Laughing at yourself may be good for mental well-being

Agencies
February 12, 2018

London, Feb 12: People who frequently crack jokes about themselves to gain approval of others have greater levels of psychological well-being, a study has found.

The findings, published in the journal Personality and Individual Differences, contradict some of the research carried out to date in the psychology of humour.

Up until now, a significant deal of the research literature has suggested that self-defeating humour is exclusively associated with negative psychological effects among individuals who regularly employ this style of humour.

"In particular, we have observed that a greater tendency to employ self-defeating humour is indicative of high scores in psychological well-being dimensions such as happiness and, to a lesser extent, sociability," said Jorge Torres Marin from University of Granada in Spain.

"The results, as well as being consistent with the positive connotations traditionally attributed to the act of 'laughing at oneself' in our country, also suggest that the effects of self-defeating humour on well-being may differ depending on where the research takes places," Marin said.

"Consequently, we believe it is necessary to conduct new studies aimed at analysing potential cultural differences in the use of this kind of humour," he said.

"Our research fits into one of the theoretical models that aim to overcome these limitations and provide the psychology of humour with a well-founded, accurate theoretical body of knowledge," said Hugo Carretero Dios, from University of Granada.

Nonetheless, researchers also point out that certain styles of humour may be employed to conceal negative intentions and feelings.

"Humour enables individuals with low scores in honesty to build trust, closeness, etc. with other people and thereby use important information in order to manipulate them or obtain advantages in the future," said Gines Navarro-Carrillo from University of Granada.

The results regarding the relationship between the use of humour and anger management suggests that the capacity for maintaining a humorous perspective in adverse situations, ie the use of self-enhancing humour, is typically found among people who manage anger more effectively, as well as among those with lower tendencies to exhibit angry feelings or reactions.

By contrast, people who tend to use aggressive or self- defeating humour do not manage anger or rage as well.

In particular, aggressive humour is mainly associated with the expression of anger towards others and a greater propensity to experience anger in everyday life.

By using aggressive humour, individuals may express negative feelings (for example, anger, superiority, hate, etc) less explicitly than they would through physical or verbal abuse, since they can allude to the humorous nature of the comments they make in order to justify them.

Self-defeating humour was linked to a greater tendency to suppress anger. However, this suppression does not necessarily mean that the anger directed at others is reduced or controlled, but rather that the triggers eliciting such angry reactions are concealed or not explicitly stated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 6,2020

Researchers have found the rates of lung cancer are higher in young women than men.

The study, published in the journal Pediatrics, examined lung cancer rates in young adults in 40 countries across five continents and uncovered a trend of higher lung cancer rates in women compared with men in recent years.

The emerging trend was widespread, affecting countries across varied geographic locations and income levels.

The changes appeared to be driven by a rising rate of adenocarcinoma lung cancer among women, said the study researchers from University of Calgary in Canada.

Lung cancer rates have been higher among men than women because men started smoking in large numbers earlier and smoked at higher rates; however, recent studies have reported converging lung cancer incidence rates between sexes.

Among men, age specific lung cancer incidence rates generally decreased in all countries, while in women the rates varied across countries with the trends in most countries stable or declining, albeit at a slower pace compared to those in men.

For the findings, lung and bronchial cancer cases between 30-64 age group from 1993-2012 were extracted from cancer incidence in five continents.

The study found the higher emerging rates of lung cancer in young women compared to young men.

According to the researchers, future studies are needed to identify reasons for the elevated incidence of lung cancer among young women.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

Tedros Adhanom Ghebreyesus, the World Health Organisation's (WHO) Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference on Monday.

The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug, he said.

"The Executive Group has implemented a temporary pause of the HCQ arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board. The other arms of the trial are continuing," Tedros added.

WHO initiated the Solidarity Trial, a plan to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19 more than two months ago, which include HCQ.

According to the WHO, over 400 hospitals in 35 countries are actively recruiting patients and nearly 3,500 patients have been enrolled from 17 countries under the Solidarity Trial.

Tedros added that the safety concern over the drug related only to the use of HCQ and chloroquine in COVID-19, and "these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria".

"WHO will provide further updates as we know more," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 27,2020

New Delhi, Mar 27: The Centre has restricted sale and distribution of "hydroxychloroquine" declaring it as an essential drug to treat the COVID-19 patients and meet the requirements of emergency arising due to the pandemic.

The Ministry of Health and Family Welfare on Thursday made the announcement making it clear that the order "shall come into force on the date of its publication in the official Gazette".

In the order, the government declared that the Central government is "satisfied that the drug hydroxychloroquine is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug 'hydroxychloroquine' and preparation based thereon for preventing their misuse".

"Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central government hereby directs that sale by retail of any preparation containing the drug Hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945."

The order came at a time when the novel coronavirus claimed 16 lives and infected over 600 people across India.

The announcement regarding ban of sale and distribution of the drug was made by the government earlier but it issued an official Gazette notification on Thursday signalling that hydroxychloroquine -- an anti-Malaria drug -- will work as a medicine for treating coronavirus infected patients as well.

Recently, the national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.